Biologics market size is expected to boost owing to the increasing product pipeline from different companies like Merck and Co., Pfizer, Glaxosmithkline. Pfizer has a strong product pipeline for 2019 of biologics, biosimilars, vaccines and small molecules. 35 products are in phase 1, 28 are in phase 2 and 26 are in phase 3 and […]
from LinkeWire https://ift.tt/2MRy4i2
from LinkeWire https://ift.tt/2MRy4i2
Comments
Post a Comment